Cargando…

Antiviral activity of silymarin and baicalein against dengue virus

Dengue is an arthropod-borne viral disease that has become endemic and a global threat in many countries with no effective antiviral drug available currently. This study showed that flavonoids: silymarin and baicalein could inhibit the dengue virus in vitro and were well tolerated in Vero cells with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Low, Zhao Xuan, OuYong, Brian Ming, Hassandarvish, Pouya, Poh, Chit Laa, Ramanathan, Babu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551334/ https://www.ncbi.nlm.nih.gov/pubmed/34707245 http://dx.doi.org/10.1038/s41598-021-98949-y

Ejemplares similares

Antiviral activity of silymarin in comparison with baicalein against EV-A71
por: Lalani, Salima S., et al.
Publicado: (2020)

Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2020)

Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
por: Moghaddam, Ehsan, et al.
Publicado: (2014)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2021)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
por: Lee, Michelle Felicia, et al.
Publicado: (2023)

Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015)

Novel antiviral activity of baicalein against dengue virus
por: Zandi, Keivan, et al.
Publicado: (2012)

The Conserved Molecular Determinants of Virulence in Dengue Virus
por: Ahmad, Zuleeza, et al.
Publicado: (2019)

Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles
por: Chan, Yanqi, et al.
Publicado: (2020)

Role of microRNAs in antiviral responses to dengue infection
por: Wong, Rui Rui, et al.
Publicado: (2020)

Peptides as Therapeutic Agents for Dengue Virus
por: Chew, Miaw-Fang, et al.
Publicado: (2017)

Innate and adaptive immune evasion by dengue virus
por: Lee, Michelle Felicia, et al.
Publicado: (2022)

Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine
por: Ramanathan, Babu, et al.
Publicado: (2016)

Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease
por: Lalani, Salima, et al.
Publicado: (2021)

Correction: Lalani, S. and Poh, C.L. Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71). Viruses 2020, 12, 184
por: Lalani, Salima, et al.
Publicado: (2020)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Development of Peptide Vaccines in Dengue
por: Reginald, Kavita, et al.
Publicado: (2018)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Antiviral Activities of Streptomyces KSF 103 Methanolic Extracts against Dengue Virus Type-2
por: Zulkifli, Nurfatihah, et al.
Publicado: (2023)

Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus
por: Johari, Jefree, et al.
Publicado: (2012)

Antivirals blocking entry of enteroviruses and therapeutic potential
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2021)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
por: Lim, Hui Xuan, et al.
Publicado: (2019)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2019)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

Recent advances in delivery of veterinary DNA vaccines against avian pathogens
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
por: Khalid, Kanwal, et al.
Publicado: (2023)

Antiviral Activities of Silymarin and Derivatives
por: Liu, Ching-Hsuan, et al.
Publicado: (2019)

Development of Novel Vaccines against Enterovirus-71
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2015)

Nanovaccines against Viral Infectious Diseases
por: Heng, Wen Tzuen, et al.
Publicado: (2022)

Impact of RNA Virus Evolution on Quasispecies Formation and Virulence
por: Mandary, Madiiha Bibi, et al.
Publicado: (2019)

Development of MicroRNAs as Potential Therapeutics against Cancer
por: Abd-Aziz, Noraini, et al.
Publicado: (2020)

Antiviral Activity of Catechin against Dengue Virus Infection
por: Yi, Bowen, et al.
Publicado: (2023)

Corrigendum to “Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers” [Antiviral Res. 107 (2014) 35–41]
por: Tan, Chee Wah, et al.
Publicado: (2014)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
por: Lim, Hui Xuan, et al.
Publicado: (2021)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
por: Al-Fattah Yahaya, Abdul Aziz, et al.
Publicado: (2023)

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2021)

Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
por: Lim, Hui Xuan, et al.
Publicado: (2020)

Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence
por: Mandary, Madiiha Bibi, et al.
Publicado: (2018)

Structural Vaccinology for Viral Vaccine Design
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2019)

Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sls30tv7bp5ooeanot9mq4ctar